Skip to search formSkip to main contentSkip to account menu

Lumateperone

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
The FDA has approved lumateperone tosylate (Caplyta™, Intra-Cellular Therapies) for treatment of schizophrenia in adults. 
2018
2018
Abstract Background Lumateperone (ITI-007) is a first-in-class investigational agent in development for the treatment of… 
2018
2018
Abstract Background Oxidative stress, coupled with dysregulation of inflammation, NMDAR and dopamine, is involved in… 
2018
2018
Abstract Background The aim of this study was to investigate the efficacy and safety of blonanserin treatment after switching… 
2018
2018
Abstract Background A six-item version (PANSS-6: P1=Delusions, P2=Conceptual disorganization, P3=Hallucinations, N1=Blunted…